Critics question India's new drug approval rules, citing fairness concerns.

New Zealand funds new CLL treatments starting May 2026.

SS Innovations unveils drone-enabled remote robotic surgery system for combat zones.

FDA rejects Replimune's melanoma drug RP1 for lack of effectiveness.

China launches AI-powered digital doctor platform for Parkinson's disease patients.

Chinese man regains movement after stroke using non-invasive mind-controlled system.

Merck extends Keytruda exclusivity with aggressive patents, costing patients over $200,000 annually.

Study links ear conditions to higher dementia risk.

Spyre Therapeutics shares surge on positive Phase 2 ulcerative colitis trial results.

President Murmu urges AIIMS Rajkot grads to embrace AI and empathy while advancing affordable healthcare for India's vision of 2047.